ArticlePharmaceutics2022

Vascular Disruptive Hydrogel Platform for Enhanced Chemotherapy and Anti-Angiogenesis through Alleviation of Immune Surveillance.

Fasheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.